The central nucleus of amygdala is involved in tolerance to the antinociceptive effect of NSAIDs

Merab G. Tsagareli, Nana Tsiklauri, Gulnazi Gurtskaia, Ivliane Nozadze, Elene Abzianidze

.

DOI: 10.4236/health.2010.21010                

Abstract

Aim: Repeated microinjections of non-opioid an-algesics into the midbrain periaqueductal gray matter and rostral ventro-medial medulla induce antinociception with development of tolerance. Antinociception following systemic administra-tion of non-steroidal anti-inflammatory drugs (N SAIDs) also exhibit tolerance. Presently our aim was to investigate the development of tolerance to the antinociceptive effects of NSAIDs analgine, ketorolac, and xefocam microinjected into cen-tral nucleus of amygdala (Ce) in rats. Methods: Under anesthesia with thiopental a stainless steel guide cannula was stereotaxically implanted uni- laterally or bilaterally into the Ce using stereo-taxic atlas coordinates, and anchored to the cra- nium by dental cement. Five days after surgery, 3 µl of these NSAIDs were injected via the injec-tion cannula while the rat was gently restrained. Twenty min post microinjection, i.e. 10-min be-fore the peak of the drugs’ effect is normally rea- ched, animals were tested with tail flick (TF) and hot plate (HP) tests. On the 5th experimental day all animals received a Ce microinjection of mor-phine. Results: Daily microinjection of NSAIDs into the Ce uni- or bilaterally, produced antino-ciception with development of complete toler-ance over a 5-day period. Following the treat-ment period, morphine microinjection into the Ce failed to elicit antinociception, indicating cro- ss-tolerance to the antinociceptive effect of N SAIDs. In other words, the “non-opioid tolerant” rats showed cross-tolerance to morphine. Con-clusions: Our data confirmed the suggestion that NSAIDs interact with endogenous opioid systems, which likely play a key role in the development of tolerance to the antinociceptive effects of NSA IDs.

Keywords

Descending Inhibition; Morphine Cross-Tolerance; Nociception

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Jones, S.L. (1996) Dipyrone into the nucleus raphe mag- nus inhibits the rat nociceptive tail flick reflex. Eur J Pharmacol, 318, 37-40.
[2]	Pernia-Andrade, A.J., Tortorici, V. and Venegas, H. (2002) Induction of opioid tolerance by lysine-acetylsalicylate in rats. Pain, 111, 191-200.
[3]	Tortorici, V., Nogueira, L., Salas, R. and Venegas, H. (2003) Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaque-ductal gray of rats. Pain, 102, 9-16.
[4]	Tortorici, V. and Vanegas, H. (2000) Opioid tolerance in- duced by metamizol (dipyrone) microinjections into the periaqueductal gray of rats. Eur J Neurosci, 12, 4074- 4080.
[5]	Tsagareli, M.G., Tsiklauri, N., Lagidze, T., Gurtskaia, G. and Abzianidze, E. (2005) Tolerance induction by non- opioid analgesics in rats. Proc Georgian Acad Sci Biol Series A, 31, 903-909.
[6]	Tsiklauri, N., Gurtskaia, G. and Tsagareli, M.G. (2006) Is endogenous opioid system involved in non-opioid anal-gesics tolerance? Georgian Med News, 8(137), 121-125.
[7]	Tsiklauri, N. and Tsagareli, M.G. (2006) Non-opioid- induced tolerance in rats. Neurophysiol, 38, 370-373.
[8]	Hernandez-Delgadillo, G.P. and Cruz, S.L. (2006) En-dogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats. Eur J Pharmacol, 546, 54-59.
[9]	Aggleton, J.P. (Ed) (1996) The amygdala: Neurobiologi-cal aspects of emotion, memory, mental dysfunction. Wil- ley-Liss, New York
[10]	Bodnar, R.J. (2000) Supraspinal circuitry mediating opioid antinociception: Antagonist and synergy studies in multi-ple sites. J Biomed Sci, 7, 181-194.
[11]	Helmstetter, F.J., Tershner, S.A. and Poore, L.H. (1998) Antinociception following opioid stimulation of the ba-solateral amygdala is expressed through the periaque-ductal grey and rostral ventromedial medulla. Brain Res, 779, 104-118.
[12]	Pavlovi?, Z., Cooper, M. and Bodnar, R. (1996) Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats. Brain Res, 741, 13-26.
[13]	Rivzi, T.A., Ennis, M. and Behbehani, M.M. (1991) Con-nections between the central nucleus of the amygdala and the midbrain periaqueductal gray: Topography and re-ciprocity. J Comp Neurol, 303, 121-131.
[14]	Gauriau, C. and Bernard, J.F. (2002) Pain pathways and parabrachial circuits in the rat. Exp Physiol, 87, 251-258.
[15]	Gauriau, C. and Bernard, J.F. (2004) A comparative re-appraisal of projections from the uperficial laminae of dorsal horn in the rat: forebrain. J Comp Neurol, 468, 24-56.
[16]	Manning, B.H. and Mayer, D.J. (1995) The central nu-cleus of the amygdala contributes to the production of morphine antinociception in the tail-flick test. J Neurosci, 15, 8199-8213.
[17]	Paxinos, G. and Watson, C. (1998) The rat brain in stereo-taxic coordinates, 4th edition. Academic Press, New York.
[18]	Morgan, M.M., Clayton, C.C. and Boyer-Quick, J.S. (2005) Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat. Pain, 113, 91-98.
[19]	Tortorici, V., Nogueira, L., Aponte, Y. and Vanegas, H. (2004) Involvement of cholecystokinin in the opioid tol-erance induced by dipyrone (metamizol) microinjections into the periaqueductal gray matter of rats. Pain, 112, 113-120.
[20]	Vanegas, H. and Tortorici, V. (2002) Opioidergic effects of non-opioid analgesics on the central nervous system. Cell Mol Neurobiol, 22, 655-661.
[21]	Price, D.D. (1999) Psychological mechanisms of pain and analgesia. IASP Press, Seattle.